联系客服

600535 沪市 天士力


首页 公告 天士力:天士力关于公司2022年度主要经营数据的公告

天士力:天士力关于公司2022年度主要经营数据的公告

公告日期:2023-03-28

天士力:天士力关于公司2022年度主要经营数据的公告 PDF查看PDF原文

      证券代码:600535        证券简称:天士力        编号:临 2023-012 号

                      天士力医药集团股份有限公司

                  关于公司 2022 年度主要经营数据的公告

          本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述

      或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。

          根据上海证券交易所发布的上市公司分行业信息披露指引《上市公司行业信

      息披露指引第六号——医药制造》等相关要求,现将公司 2022 年度主要经营数据

      披露如下:

          一、报告期内分行业经营数据

                                                                  单位:元  币种:人民币

                  主营业务收入                            主营业务成本                  毛利率(%)

                                        增长                                    增长          上年

行业                                    率                                      率    本期          增长
        本期累计      上年同期累计    (%      本期累计      上年同期累计  (%  累计  同期    率
                                        )                                      )          累计

医药  7,145,794,544.98  6,654,091,503.55  7.39  2,045,781,708.20  1,763,147,188.18  16.03  71.37  73.50  -2.13
工业

医药  1,416,591,221.92  1,244,008,754.64  13.87  1,030,594,928.97  885,050,183.19  16.44  27.25  28.85  -1.61
商业

合计  8,562,385,766.90  7,898,100,258.19  8.41  3,076,376,637.17  2,648,197,371.37  16.17  64.07  66.47  -2.40

                                                                      单位:元  币种:人民币

 分治疗领域        营业收入          营业成本      毛利率  营业收入比上  营业成本比上  毛利率比上年增
                                                    (%)  年增减(%)  年增减(%)    减(%)

  心脑血管      5,078,235,157.94  1,383,739,967.20      72.75          6.09        17.21            -2.58

  抗肿瘤        315,074,944.95    109,732,537.32      65.17        -19.71          -9.16            -4.04

  感冒发烧        429,387,390.11    207,650,454.93      51.64        49.51        43.96            1.87

  肝病治疗        581,515,522.27      99,840,640.49      82.83          5.95          3.97            0.33


 分治疗领域        营业收入          营业成本      毛利率  营业收入比上  营业成本比上  毛利率比上年增
                                                    (%)  年增减(%)  年增减(%)    减(%)

    其他          741,581,529.71    244,818,108.26      66.99        16.09        10.55            1.66

医药工业小计    7,145,794,544.98  2,045,781,708.20      71.37          7.39        16.03            -2.13

医药商业小计    1,416,591,221.92  1,030,594,928.97      27.25        13.87        16.44            -1.61

    合计        8,562,385,766.90  3,076,376,637.17      64.07          8.41        16.17            -2.40

                                                                    单位:元  币种:人民币

                                                  毛利率  营业收入比  营业成本比上  毛利率比上年增减
  分产品        营业收入        营业成本      (%)    上年增减    年增减(%)        (%)

                                                              (%)

    中药        5,556,686,590.62  1,655,924,901.05    70.20          9.38        20.46              -2.74

 化学制剂药    1,270,351,832.52    266,540,981.67    79.02          1.19          -2.69                0.84

 化学原料药      71,122,501.65    32,054,397.09    54.93          5.69        16.86              -4.31

  生物药        247,633,620.19    91,261,428.39    63.15        -1.49          4.77              -2.20

 医药工业小计    7,145,794,544.98  2,045,781,708.20    71.37          7.39        16.03              -2.13

 医药商业小计    1,416,591,221.92  1,030,594,928.97    27.25        13.87        16.44              -1.61

    合计        8,562,385,766.90  3,076,376,637.17    64.07          8.41        16.17              -2.40

          公司感冒发烧产品收入较去年同期增长 49.51%,主要系穿心莲内酯滴丸和藿

      香正气滴丸销量增加所致。

          二、报告期内分地区经营数据

                                                                单位:元 币种:人民币

          地区            本期累计主营业务收入    上年同期累计主营业务收入        增长比例(%)

        天津市                  13,209,902,399.33              12,285,594,167.40                      7.52

        广东省                      2,099,081.65                  20,730,744.23                    -89.87

        山东省                    284,324,255.79                248,753,294.11                      14.30

        陕西省                    93,832,957.89                  78,302,631.02                      19.83

        辽宁省                    967,138,199.48                862,456,838.56                      12.14

        江苏省                    910,277,276.16                891,556,568.43                      2.10


 地区            本期累计主营业务收入    上年同期累计主营业务收入        增长比例(%)

 上海市                    247,633,620.19                251,370,868.88                      -1.49

 其他                    225,016,013.79                181,942,288.75                      23.67

 小计                  15,940,223,804.28              14,820,707,401.38                      7.55

 抵消                    7,377,838,037.38              6,922,607,143.19                      6.58

 合并                    8,562,385,766.90              7,898,100,258.19                      8.41

注:上表中地区分布以公司所在地划分。

  广东省销售收入比上年同期下降 89.87%,主要系公司连锁
[点击查看PDF原文]